The release of the COURAGE trial results has fuelled the debate over the benefits of
percutaneous coronary interventions (PCI) in stable angina [1]. To date PCI, when compared …

Although the benefits of percutane-ous coronary intervention (PCI) are unquestionable in
acute coronary syndromes, the clinical results are not so clear in stable angina. Thus, the …

Appropriate indications and prognostic benefits of percutaneous coronary intervention (PCI)
remain controversial in patients with stable coronary artery disease (CAD). In the COURAGE …

Percutaneous coronary intervention (PCI) is an important form of revascularization therapy
that has potential benefits but also significant risks. In patients with an acute coronary …

Background—The COURAGE (Clinical Outcomes Utilizing Revascularization and
Aggressive Drug Evaluation) trial was designed to compare optimal medical therapy alone …

The role of percutaneous coronary intervention (PCI) in patients with ST elevation
myocardial infarction (STEMI) is clear (European Society of Cardiology STEMI Guideline …

The number of percutaneous coronary interventions is increasing, especially for the
management of chronic stable angina. However, for these patients there is no evidence of a …

The debate over coronary revascularization in stable ischemic heart disease has grown over
the past decade, sparked by the landmark COURAGE (Clinical Outcomes Utilizing …

© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2012;
2 (4): 264-267 www. thecdt. org highly significant difference in the rate of the primary end …

New England Journal of Medicine [1]. The trial has been praised and assailed, not
surprisingly, by individuals whose subspecialty interest would predict the likelihood of their …